• Co-develop, write and deliver a Phase 3 protocol in timely manner,• Contributed to the preparation of an FDA submission package (90-day safety update, Safety narratives and Efficacy narratives),• Conduct ongoing clinical review/query resolution of clinical trial data and monitor trends on a phase II studies• Supported the submission of a clinical trial publication to a major medical journal (The Lancet)

• Maintain a thorough understanding of assigned protocol and educate supportive team members• Conduct ongoing clinical review/query resolution of clinical trial data and monitor trends on phase I and II studies• Assess and ensure protocol compliance by raising relevant protocol deviations• Ensure consistency and quality data by supporting clinical global team; act active member of the Data Quality Team • Review of several trial- and program-level documents (ICF, TFL, SAP, CDP… Show more • Maintain a thorough understanding of assigned protocol and educate supportive team members• Conduct ongoing clinical review/query resolution of clinical trial data and monitor trends on phase I and II studies• Assess and ensure protocol compliance by raising relevant protocol deviations• Ensure consistency and quality data by supporting clinical global team; act active member of the Data Quality Team • Review of several trial- and program-level documents (ICF, TFL, SAP, CDP, PPSR…)• Participate in the elaboration of protocol amendments • Act as an active member of the trial Steering Committee, the Global Clinical Team, with regular contributions and presentations to the KOLs and at program-level• Provide training and serve as primary contact for clinical questions for site-facing activities; present these at monthly countries’ calls, and share these in the site newsletters• Improve the CRF during the study and update it in alignment with amendments, with the support of the other relevant Clinical Trial Team’s functions• Support the imaging vendor for clinically relevant challenges Show less

• Acted as Subject Matter Expert for the GMP Production Unit of < CD19 > CAR-T cell therapy Kymriah, providing experienced front-line scientific support,• Troubleshooted process and product-related deviations within the PU in collaboration with MS&T, AS&T, QA and QC colleagues.

• Lead a translational early development project aiming to develop a new bifunctional protein (from its design to its non-clinical evaluation in combination with CAR-T cells) and contribute to 2 other projects • Worked in close collaboration with 6 different departments within Roche and with top academic partners at a European level (leading to co-authorship), • Gave regular presentations (posters & talks) at internal and international conferences to KOLs within the field of… Show more • Lead a translational early development project aiming to develop a new bifunctional protein (from its design to its non-clinical evaluation in combination with CAR-T cells) and contribute to 2 other projects • Worked in close collaboration with 6 different departments within Roche and with top academic partners at a European level (leading to co-authorship), • Gave regular presentations (posters & talks) at internal and international conferences to KOLs within the field of Onco-Immunology at a European levelWithin Pharmaceutical Research and Early Development (pRED), Roche Innovation Center Munich, Large Molecule Research (LMR), and Immutrain - European Training Network for the Immunotherapy of Cancer, in close collaboration with the Department of Clinical Pharmacology, Ludwig Maximilian University of Munich. Show less

Within the research unit UMR 8015, headed by Pr. Nicolas Leulliot. Project supervised by Dr S. Lebaron: • Developed peptide for in vitro validation of innovative anticancer therapeutic target regulating both ribosome biogenesis and p53 tumor suppressor (via the RPS14-MDM2-p53 pathway)

Within the research unit UMR 8015, headed by Pr. Nicolas Leulliot. Project supervised by Dr. M. Blaud, Ph.D.:• Biophysical & biochemical approach for structural & functional characterization of protein complex involve in ribosome biogenesis

• Follow-up of patients of Dr. A. Sola Gazagnes, MD & Prof. E. Larger, MD • Therapeutic education of patients

• Assisted and realized myelograms for blood cancer diagnosis • Blood and bone marrow based diagnosis • Active participation in hemostasis consultation of Dr. M-H. Horellou, MD

Within the research Unit UMRS 1138 headed by Dr. Jean-Luc Teillaud. Project supervised by Dr. Sophie Sibéril & Dr. Jean-Luc Teillaud:• Studied the impact of in vivo B cell depletion via anti-CD20 mAb on T cell compartment in miceUMRS 1138 – Equipe 13 “Cancer & Immunité anti-tumorale”, dirigé par Dr. Jean-Luc TEILLAUD & Pr. Isabelle CREMER

Adidas Factory Outlet in Claye-Souilly:- Assembly-line work- Inventory Organization